BCPC Balchem Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 85
Relative Strength: Rel. Strength: 35
Relative Valuation: Rel. Valuation: 40
Relative Profitability: Rel. Profitability: 78

EPS in 2025 (TTM): $4.6

Last Report Period Date: Sep 30, 2025

Currently, BCPC's 12-month EPS stands at $4.6, according to the most recent financial reports. During 2024, BCPC reported a per-share earnings of $3.97, which shows a rise compared to the EPS of $3.38 recorded in 2023. BCPC recorded an EPS of $1.25 for the quarterly period ending on Sep 30, 2025.

BCPC earnings history

Historical annual and quarterly earnings per share (EPS) data for Balchem
EPS (TTM)
$4.6
EPS Growth YoY (Quarterly)
19%
EPS (Quarterly)
$1.25
EPS Growth (Quarterly)
5.9%

In 2024, Balchem's earnings per share was $3.97, a rise of 17.5% from $3.38 in 2023. Over the quarter ending Sep 30, 2025, the earnings per share came in at $1.25, reflecting a 19% increase compared to the same quarter a year earlier. As of September 2025, the TTM EPS is $4.6. During 2023, the annual earnings per share was $3.38, representing an increase of 2.7% compared to 2022.

BCPC EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
19%
EPS growth YoY
17.5%
EPS growth 3Y avg
10%
EPS growth 5Y avg
9.9%

Balchem has recorded a growth in earnings per share of 19% in the past 12 months (YoY, quarterly). During the past three years, BCPC registered an average yearly EPS growth of 10%. Balchem had an average annual EPS growth of 9.9% in the last five years. Over the last decade, BCPC had an average annual earnings per share growth of 8.6%.

BCPC Earnings Waterfall

Breakdown of revenue, profit and net income for Balchem

BCPC Earnings vs Peers

What are the earnings of BCPC compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
EMN Eastman Chemical Co 10.1 2.8% 6.9% 7%
MMM 3M Co 26.04 160% -9.5% -0.6%
BCPC Balchem Corp 33.2 17.5% 10% 9.9%
STE STERIS plc 37.01 62.9% 35.6% 5.3%
IFF International Flavors & Fragrances Inc N/A 109.5% -5.1% -25.2%
CDXS Codexis Inc N/A 20.5% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.